We have recently demonstrated that L-GILZ exerts antiproliferative and anti-oncogenic activity by activating p535, as interactions between L-GILZ, p53, and mouse double minute 2 (MDM2) led to the activation of p53 and inhibition of tumor cell growth5,7. Here, TSC22D3 is linked to neoplasm.